IMRX – immuneering corporation - class a (US:NASDAQ)
Stock Stats
News
Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference
Immuneering Co. (NASDAQ: IMRX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $13.00 price target on the stock.
Immuneering Corporation Announces Grant of Inducement Award
Immuneering Co. (NASDAQ: IMRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Immuneering GAAP EPS of -$0.58 [Seeking Alpha]
Form 4 Immuneering Corp For: Mar 21 Filed by: Matushansky Igor
Form 3 Immuneering Corp For: Mar 17 Filed by: Matushansky Igor
Form 424B5 Immuneering Corp
Form 10-K Immuneering Corp For: Dec 31
Form 8-K Immuneering Corp For: Mar 20
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.